Search for: "Abbott Products, Inc."
Results 581 - 600
of 663
Sort by Relevance
|
Sort by Date
23 Jan 2009, 5:26 am
Abbott Laboratories, 123 N.C. [read post]
22 Jan 2009, 2:06 am
Wyeth, Inc., 168 Cal. [read post]
20 Jan 2009, 4:46 pm
Recalls Peanut Butter Cookies and Bars Because of Possible Health Risk (January 19) * Clif Bar & Company Announces Voluntary Nationwide Recall of CLIF® and LUNA® Branded Bars Containing Peanut Butter Due to Possible Health Risk (January 19) * Kroger Recalls Select Ice Cream Products Due to Possible Health Risk (January 19) * Abbott Nutrition Announces Voluntary Recall of ZonePerfect® Chocolate Peanut Butter Bars, ZonePerfect® Peanut Toffee… [read post]
20 Jan 2009, 4:46 pm
* Nash Finch Recalls Bakery Products With Peanut Butter Distributed in Seven States Due to Possible Health Risk (January 20) * Aspen Hills, Inc. [read post]
19 Jan 2009, 2:45 pm
Those companies include: · Abbott Nutrition [recall of ZonePerfect Chocolate Peanut Butter Bars, ZonePerfect Peanut Toffee Bars and NutriPals Peanut butter Chocolate Bars] · Meijer [recall of their two brands of crackers and two types of ice cream] · Ralcorp [recall of Wal-Mart bakery brand peanut butter cookies] · Ralcorp [recall of Lofthouse Peanut butter cookies, Chuck’s chunky peanut… [read post]
18 Jan 2009, 2:29 pm
More products with Peanut Butter in them are being recalled. [read post]
9 Jan 2009, 7:00 am
(IP Think Tank) IEEE patent scorecard for 2008 is out (Innovationpartners) (Peter Zura's 271 Patent Blog) Patent databases: 2008 in review (Patent Librarian's Notebook) New kind codes for republished PCT documents (Patent Librarian’s Notebook) The model changes at PatentFreedom; Matsushita is top troll target (IAM) Patent litigation, the ITC, and hardship in the chip industry (IP finance) Global - Copyright Public domain day 2009 (Creative Commons), (Michael Geist)… [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel… [read post]
6 Jan 2009, 9:14 am
Abbott Labs: - Deemed Quanta déjà vu, it concerns whether product-by-process claims are infringed by sale of a claimed product produced by a different method. [read post]
9 Dec 2008, 7:03 am
The company has a wide variety of clients, including IBM, Genereal Electric, Motorola, Abbott Laboratories, and Eastman Koday. [read post]
1 Dec 2008, 7:40 pm
See eBay Inc. v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
21 Nov 2008, 4:13 pm
Earhart was a corporate officer and the President of the Optical Division of Allergan, Inc. [read post]
21 Nov 2008, 1:36 pm
’ paper by Graeme Clark SC (IP Down Under) Full Federal Court decision concerning brand reputation in context of ‘lookalike’ products and famous brands: Hansen Beverage Company v Bickfords (Australia) Pty Ltd (Mallesons Stephen Jaques) Federal Court holds that grace period applicable to a ‘parent patent’ is different to that of its divisional ‘child’: Mont Adventure Equipment v Phoenix Leisure Group (IP Down Under) Design… [read post]
13 Nov 2008, 5:27 pm
In this light, the real anti-competitive harm from Abbott and Fournier’s product hopping is straightforward. [read post]
13 Nov 2008, 1:52 pm
Abbott Laboratories, 607 P.2d 924, (Cal. 1980). [read post]
7 Nov 2008, 3:42 am
No problem: In re Ciprofloxacin Hydrochloride Antitrust Litigation (Patent Baristas) US: FTC Commissioner speaks out on follow-on biologics – current initiatives and long-term goals (FDA Law Blog) US: Hatch-Waxman Act-related lawsuits likely to drop, but generic companies may start to challenge biotechnology patents, says David Pritikin (Law360) US: Sequenom sues rival genetic research company Ibis Biosciences alleging infringement of DNA analysis patents (Law360) … [read post]
25 Oct 2008, 12:03 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Biaxin (Clarithromycin) - US: New standard for materiality: Abbott Laboratories v. [read post]
23 Oct 2008, 10:31 am
" Specifically, "infections triggered safety alerts for the arthritis medicines Enbrel (etanercept), sold by Amgen Inc.; Johnson & Johnson's Remicade (infliximab); and Abbott Laboratories' Humira (adalimumab). [read post]
2 Oct 2008, 12:36 pm
Nov. 13, 2006); In re Rezulin Products Liability Litigation, 133 F. [read post]
